E-cigarettes and obstetric outcomes: a prospective observational study
To compare the obstetric outcomes and socio‐demographic factors in electronic cigarette (EC) users with cigarette smokers and non‐smokers in pregnancy.
E-cigarettes and smoking cessation in the US according to frequency of e-cigarette use and quitting duration: analysis of the 2016 and 2017 National Health Interview Surveys
The purpose of this study was to examine the association between electronic cigarette (e-cigarette) use and smoking cessation among US adults.
Effectiveness and safety of electronic cigarettes among sole and dual user vapers in Kuantan and Pekan, Malaysia: A six-month observational study
Current studies on electronic cigarettes (ECs) have assessed the smoking cessation effectiveness and safety of EC among sole EC users. However, in Malaysia and elsewhere, most EC users also smoke conventional cigarettes (CCs).
Fear Profiteers – How E-cigarette Panic Benefits Health Activists
That the public perception of e-cigarettes diverts so radically from the actual evidence raises the question: Why? This paper makes the case that the confusion is the intended result of an orchestrated disinformation campaign led by individuals and groups that ought to be among the most supportive of lower-risk tobacco alternatives—anti-smoking health advocates.
Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked
Abstract: Although electronic cigarettes (ECs) are a much less harmful alternative to tobacco cigarettes, there is concern as to whether long-term ECs use may cause risks to human health.
How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor
ims: To propose a hierarchy of methodological criteria to consider when determining whether a study provides sufficient information to answer the question of whether e-cigarettes can facilitate cigarette smoking cessation or reduction.
A Qualitative Analysis of Maori and Pacific people’s Experiences of Using Electronic Nicotine Delivery Systems (ENDS)
If electronic nicotine delivery systems (ENDS) are to bring public health benefits, members of population groups most affected by smoking must find them an easily adopted and satisfying replacement for smoking. We explored experiences of ENDS uptake and use among Māori and Pacific peoples living in New Zealand and probed factors that assisted transitions from smoking to vaping.
E-cigarettes and electronic nicotine delivery systems: a word of caution on health and new product development
This paper describes the introduction, development, and proliferation of new electronic nicotine delivery systems. The use of non-combustible tobacco products is considered a means for improving public health and reducing the mortality attributed to cigarette smoking.
Electronic nicotine delivery systems (ENDS): the beginning of the end or the end of the beginning?
5 million people in the world die of active smoking and more than 600 000 nonsmokers die from exposure to passive smoke annually
Evidence review of e-cigarettes and heated tobacco products 2018
Regulations need to balance the risks of e-cigarettes with their potential benefits – and achieve key aims of reducing smoking and continuing to avoid uptake of e-cigarettes by non-smokers. This requires keeping them under regular review and evaluating their impact. Regulations for heated tobacco products should be made as least a stringent as for e-cigarettes
Experts Urge Asian Authorities to Endorse Tobacco Harm Reduction
A panel of experts from CAPHRA, have sent a letter to the top ministers of nine Asian-Pacific countries, asking them to emphasise on the implementation of tobacco harm reduction policies at the Parties to the WHO’s Framework Convention on Tobacco Control (FCTC) to be held later this year.
Nicotinic Cholinergic System and COVID-19: Identification of a Potentially Crucial Snake Toxin-Like Sequence in the SARS-CoV-2 Spike Glycoprotein
.... case series have shown that there is an unexpectedly low prevalence of smoking among hospitalized COVID-19 cases.
Will Nicotine Be a Game Changer for COVID-19 Patients?
A clinical trial is set to begin in France, providing nicotine patches to hospital staff and COVID-19 patients and measuring the results. The trial has the backing of celebrated Pasteur Institute neurobiologist Jean-Pierre Changeux, an expert on the cholinergic system (which includes the nicotinic receptors).
FDA Admits There’s Actually No Evidence Vaping Makes COVID-19 Worse
The federal agency had previously stated that vapers were at an elevated risk of developing complications tied to COVID-19.
FDA Warns Manufacturers and Retailers to Remove Certain E-cigarette Products Targeted to Youth from the Market
The FDA is focused on manufacturers and retailers that make and sell ENDS products that are targeted to youth and increase their appeal. The public should really be outraged by these products
If you fail to find any relevant information in a search, please return to the previous page via the button below and start a new search.